Literature DB >> 14234779

DRUG RESISTANCE OF ENTERIC BACTERIA. 3. ACQUISITION OF TRANSFERABILITY OF NONTRANSMISSIBLE R(TC) FACTOR IN COOPERATION WITH F FACTOR AND FORMATION OF FR(TC).

K HARADA, M KAMEDA, M SUZUKI, S MITSUHASHI.   

Abstract

Harada, Kenji (Gunma University, Maebashi, Japan), Mitsuo Kameda, Mitsue Suzuki, and Susumu Mitsuhashi. Drug resistance of enteric bacteria. III. Acquisition of transferability of nontransmissible R(TC) factor in cooperation with F factor and formation of FR(TC). J. Bacteriol. 88:1257-1265. 1964.-Transmissible drug-resistance factor R, which confers resistance to tetracycline, chloramphenicol, streptomycin, and sulfonamide, was previously found to be transduced in the system of the Salmonella E group with phage epsilon. The R factor of R(+) transductants was nontransmissible by cell-to-cell contact, and it was not eliminated by treatment with acridine dye. When R(+) transductants were infected with F factor, the nontransmissible R factor acquired transferability by conjugation. The R(+) conjugants, to which only the R factor was separately transmitted by conjugation from the (F(+)R(+)) donor, were still unable to transfer their R factor by conjugation. However, the (FR)(+) conjugants, to which both F and R factor were transmitted simultaneously by conjugation, were also capable of transferring their F and R factors by conjugation. From the present study, it was concluded that the recombinant (FR) factor was formed as a result of an interaction between F and R factors present in a host bacterium, and that one of the mechanisms of acquisition of transferability is accounted for by the formation of recombinant (FR) factor. The recombinant (FR) factor was transferable by conjugation, and it conferred both the drug-resistance and F(+) characters to the recipient cells. The (FR) factor was eliminated by treatment with acridine dye and also transduced as one unit into Escherichia coli K-12 by P1kc phage.

Entities:  

Keywords:  ACRIDINES; CHLORAMPHENICOL; DRUG RESISTANCE, MICROBIAL; ESCHERICHIA COLI; EXPERIMENTAL LAB STUDY; GENETICS; MUTATION; PHARMACOLOGY; SALMONELLA; STREPTOMYCIN; TETRACYCLINE

Mesh:

Substances:

Year:  1964        PMID: 14234779      PMCID: PMC277402          DOI: 10.1128/jb.88.5.1257-1265.1964

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  12 in total

1.  On the drug-resistance of enteric bacteria. 6. Spontaneous and artificial elimination of transmissible drug-resistance factors.

Authors:  S MITSUHASHI; K HARADA; M KAMEDA
Journal:  Jpn J Exp Med       Date:  1961-04

2.  Transduction of linked genetic characters of the host by bacteriophage P1.

Authors:  E S LENNOX
Journal:  Virology       Date:  1955-07       Impact factor: 3.616

3.  THE EFFECT OF ACRIDINE DYES ON MATING TYPE FACTORS IN ESCHERICHIA COLI.

Authors:  Y Hirota
Journal:  Proc Natl Acad Sci U S A       Date:  1960-01       Impact factor: 11.205

4.  Inhibition of multiplication of an Flac factor in Hfr cells of Escherichia coli K-12.

Authors:  J SCAIFE; J D GROSS
Journal:  Biochem Biophys Res Commun       Date:  1962-05-11       Impact factor: 3.575

5.  Combination of two types of transmissible drug-resistance factors in a host bacterium.

Authors:  S MITSUHASHI; K HARADA; H HASHIMOTO; M KAMEDA; M SUZUKI
Journal:  J Bacteriol       Date:  1962-07       Impact factor: 3.490

6.  Transmission of colicinogeny between strains of Salmonella typhimurium grown together.

Authors:  H OZEKI; B A STOCKER; S M SMITH
Journal:  J Gen Microbiol       Date:  1962-09

7.  Mutants of Escherichia coli requiring methionine or vitamin B12.

Authors:  B D DAVIS; E S MINGIOLI
Journal:  J Bacteriol       Date:  1950-07       Impact factor: 3.490

8.  PROPERTIES OF F' STRAINS OF ESCHERICHIA COLI SUPERINFECTED WITH F-LACTOSE AND F-GALATOSE EPISOMES.

Authors:  H Echols
Journal:  J Bacteriol       Date:  1963-02       Impact factor: 3.490

9.  Isolation of a bacteriophage specific for the F plus and Hfr mating types of Escherichia coli K-12.

Authors:  T LOEB
Journal:  Science       Date:  1960-03-25       Impact factor: 47.728

10.  DRUG RESISTANCE OF ENTERIC BACTERIA. II. TRANSDUCTION OF TRANSMISSIBLE DRUG-RESISTANCE (R) FACTORS WITH PHAGE EPSILON.

Authors:  K HARADA; M KAMEDA; M SUZUKI; S MITSUHASHI
Journal:  J Bacteriol       Date:  1963-12       Impact factor: 3.490

View more
  16 in total

Review 1.  Colicinogeny and related phenomena.

Authors:  K G Hardy
Journal:  Bacteriol Rev       Date:  1975-12

2.  DNA cloning: a personal view after 40 years.

Authors:  Stanley N Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-16       Impact factor: 11.205

Review 3.  Drug resistance plasmids.

Authors:  S Mitsuhashi
Journal:  Mol Cell Biochem       Date:  1979-08-15       Impact factor: 3.396

Review 4.  Molecular structure of bacterial plasmids.

Authors:  R C Clowes
Journal:  Bacteriol Rev       Date:  1972-09

5.  Formation of recombinants between nontransmissible drug-resistance determinants and transfer factors.

Authors:  S Mitsuhashi; M Kameda; K Harada; M Suzuki
Journal:  J Bacteriol       Date:  1969-03       Impact factor: 3.490

Review 6.  Phylogenetic relationships of drug-resistance factors and other transmissible bacterial plasmids.

Authors:  E Meynell; G G Meynell; N Datta
Journal:  Bacteriol Rev       Date:  1968-03

Review 7.  Extrachromosomal inheritance in bacteria.

Authors:  R P Novick
Journal:  Bacteriol Rev       Date:  1969-06

8.  Association between colicinogenic and fertility factors.

Authors:  R Nagel De Zwaig
Journal:  Genetics       Date:  1966-08       Impact factor: 4.562

9.  Loss and repair of conjugal fertility and infectivity of the resistance factor and sex factor in Escherichia coli.

Authors:  Y Hirota; T Fujii; Y Nishimua
Journal:  J Bacteriol       Date:  1966-03       Impact factor: 3.490

10.  Drug resistance of enteric bacteria. 8. Chromosomal location of nontransferable R factor in Escherichia coli.

Authors:  K Harada; M Kameda; M Suzuki; S Shigehara; S Mitsuhashi
Journal:  J Bacteriol       Date:  1967-04       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.